Unibest 优贝德
Login / Register
API (Commercialized)GMP/DMFAnimal Health

Fluralaner

Long-acting eradication of fleas and ticks in dogs and cats

CAS No.
864731-61-3
Indication Class
Animal Health
Patent Expiry
To be assessed
Therapeutic Area
Animal Health
Labeled Purity
99%+
Registration Readiness
GMP/DMF
Commercialization Tier
API (Commercialized)
Linked Intermediates
5 key intermediates available
Isoxazoline ClassLong-acting Oral/TopicalPet Parasiticide

Key Intermediates for This API

Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higher

Listing Logic · Why It's Worth Listing

A mainstream pet parasiticide with single-dose long protection; rising global pet-care spending sustains growing animal-health API demand.

Demand

Animal Health · Marketed; available for immediate sourcing

Compliance

GMP/DMF-ready; supports regulatory filing and audit in target markets

Supply

5 key intermediates available; scale-up and cost control manageable

Product Description

Fluralaner is an isoxazoline insecticide. It efficiently kills various ectoparasites such as fleas and ticks through its unique mechanism of action, and is widely used for parasite prevention in companion animals (dogs, cats), as well as in the field of public health for controlling vectors of disease transmission.

Supply source: Unibest · Fluralaner, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.